Physician profile
Christopher Alexander
NPI 1922077494
$358.58
in general payments reported to CMS, 2019-2025
10 companies · $20.72 in 2025
The $20.72 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.74 · 2020: $40.06 · 2021: $24.71 · 2022: $26.09 · 2023: $106 · 2024: $41.88 · 2025: $20.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $168.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $86.26 | 2022-2023 | |
| Seaspine Orthopedics Corporation | $45.54 | 2019 | |
| Stryker Corporation | $42.11 | 2019-2025 | Aequalis Perform Reversed |
| Smith+Nephew, INC. | $41.88 | 2024 | Microraptor |
| Viiv Healthcare Company | $40.06 | 2020 | |
| Si-Bone, INC. | $33.81 | 2023 | |
| Masimo Corporation | $24.71 | 2021 | |
| Zimmer Biomet Holdings, INC. | $19.13 | 2019 | |
| Nuvasive, INC. | $12.68 | 2019 | |
| Bioventus LLC | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.